Claret Medical now a part of Boston Scientific

Claret Medical is now part of Boston Scientific. Claret Medical was founded with the realization that one stroke is one too many, and any stroke has a devastating and unpredictable impact on a patient’s life and family. With that vision, Claret Medical has developed the SENTINEL™ Cerebral Protection System, a medical device that captures and removes debris during Transcatheter Aortic Valve Replacement (TAVR), and offers protection against the risk of stroke during the procedure and shortly thereafter. The SENTINEL Cerebral Protection System is the only Embolic Protection Device currently available to TAVR patients. SENTINEL clinical study has shown usage of SENTINEL CPS to reduce TAVR peri-procedural strokes by 63%. Claret Medical has been the leader in the field of cerebral protection since 2011, with approximately 97% market share in Europe, and is the first in the category to be commercially available in the U.S. For more information on SENTINEL CPS, follow Boston Scientific Cardiology.